This is not entirely surprising given the CHD PRS includes SNPs in pathways relevant to hyperlipidemia, such as two influential SNPs (rs186696265 and rs10455872) residing near the LPA gene [30–32], which is known to increase levels of lipoprotein (a), a well-established atherogenic lipoprotein. The gene discussed is LPA; the disease is coronary artery disorder.